Published in Diagn Microbiol Infect Dis on October 01, 2007
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
Protective antigens against glanders identified by expression library immunization. Front Microbiol (2011) 0.90
Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence (2012) 0.78
Serum biomarkers of Burkholderia mallei infection elucidated by proteomic imaging of skin and lung abscesses. Clin Proteomics (2015) 0.77
Development of reagents and assays for the detection of pathogenic Burkholderia species. Faraday Discuss (2011) 0.76
Immunoreactivity of the AAA+ chaperone ClpB from Leptospira interrogans with sera from Leptospira-infected animals. BMC Microbiol (2016) 0.75
Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet (2004) 6.14
Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol (2007) 3.90
Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A (2002) 2.70
The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun (2011) 2.00
Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J Bacteriol (2005) 1.71
Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Antimicrob Agents Chemother (2007) 1.59
Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei. J Med Microbiol (2004) 1.47
Anthrax capsule vaccine protects against experimental infection. Vaccine (2004) 1.38
Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Vaccine (2005) 1.36
The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog (2004) 1.34
Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series. Vaccine (2006) 1.22
Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect Immun (2004) 1.22
Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem (2005) 1.17
Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice. Infect Immun (2002) 1.16
Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog (2005) 1.14
Molecular epidemiology of glanders, Pakistan. Emerg Infect Dis (2009) 1.07
Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Diagn Microbiol Infect Dis (2006) 1.06
Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect Immun (2006) 1.05
Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages. Infect Immun (2009) 1.03
Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements. BMC Microbiol (2010) 1.02
Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice. Vaccine (2005) 0.99
Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. Clin Diagn Lab Immunol (2005) 0.98
CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Vaccine (2009) 0.89
An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals. Vaccine (2008) 0.89
The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model. Infect Immun (2007) 0.88
Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys. Vaccine (2011) 0.81
Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencing. Appl Environ Microbiol (2013) 0.80
Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay. Mol Cell Probes (2009) 0.79
High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus. Emerg Infect Dis (2017) 0.78
Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence (2012) 0.78
An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland. Mil Med (2005) 0.77